Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
New diet may lower diabetes risk | 4.2M Abbott devices recalled | HeartFlow raises $215M
Monday, April 10, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New diet, an updated take on intermittent fasting, may lower risk of type 2 diabetes

This new approach, which combines traditional intermittent fasting with 20-hour fasting periods on nonconsecutive days, could make a big impact on the cardiovascular health of high-risk patients.

READ MORE >
clock
Share on Twitter Share on Facebook Share on Linkedin

New diet, an updated take on intermittent fasting, may lower risk of type 2 diabetes

Share on Twitter Share on Facebook Share on Linkedin
clock
This new approach, which combines traditional intermittent fasting with 20-hour fasting periods on nonconsecutive days, could make a big impact on the cardiovascular health of high-risk patients.
READ MORE >

FDA announces recall of 4.2M Abbott devices after hundreds of incidents, including multiple fires

Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of 4.2M Abbott devices after hundreds of incidents, including multiple fires

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
Abbott previously issued a voluntary medical device correction about this problem, but no recall had been announced at that time. The recall includes devices distributed from November 2017 to February 2023.
READ MORE >

HeartFlow raises $215M to keep up with growing demand

The company is still riding the momentum of its technology being included in the 2021 American College of Cardiology/American Heart Association chest pain guidelines.

READ MORE >
An example of the FFR-CT technology from Heartflow. The vendor's AI can take a patient's cardiac CT scan and non-invasively assess FFR hemodynamic flow for all the coronary arteries to determine if blockages are significant enough to require revascularization. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow raises $215M to keep up with growing demand

Share on Twitter Share on Facebook Share on Linkedin
An example of the FFR-CT technology from Heartflow. The vendor's AI can take a patient's cardiac CT scan and non-invasively assess FFR hemodynamic flow for all the coronary arteries to determine if blockages are significant enough to require revascularization. Photo by Dave Fornell
The company is still riding the momentum of its technology being included in the 2021 American College of Cardiology/American Heart Association chest pain guidelines.
READ MORE >

Featured Articles

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 

READ MORE >
Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS
Share on Twitter Share on Facebook Share on Linkedin

Intravascular imaging-guided PCI boosts outcomes, but utilization remains low

Share on Twitter Share on Facebook Share on Linkedin
Eric Secemsky, MD, FACC, FAHA, FSCAI, FSVM, director of vascular intervention at Beth Israel Deaconess Medical Center, Boston, Massachusetts, presented the results of a real-world evidence study of data for over 1 million U.S. Medicare patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging during percutaneous coronary interventions (PCI). #IVUS
Eric Secemsky, MD, told Cardiovascular Business that a lack of training is one of the biggest factors limiting the use of intravascular imaging-guided PCI among interventional cardiologists. 
READ MORE >

Antibiotic recalled due to risk of endocarditis, other life-threatening infections

According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.

READ MORE >
FDA Recall
Share on Twitter Share on Facebook Share on Linkedin

Antibiotic recalled due to risk of endocarditis, other life-threatening infections

Share on Twitter Share on Facebook Share on Linkedin
FDA Recall
According to an advisory on the FDA’s website, there is a “reasonable probability” that any immunocompromised patients exposed to the affected antibiotic could develop a life-threatening infection.
READ MORE >

ACURATE neo2 valve linked to successful commissural alignment during TAVR

The new Boston Scientific valve received CE mark approval in 2020, but has not been approved by the FDA.

READ MORE >
Boston Scientific Acurate neo2 TAVR
Share on Twitter Share on Facebook Share on Linkedin

ACURATE neo2 valve linked to successful commissural alignment during TAVR

Share on Twitter Share on Facebook Share on Linkedin
Boston Scientific Acurate neo2 TAVR
The new Boston Scientific valve received CE mark approval in 2020, but has not been approved by the FDA.
READ MORE >

PHOTO GALLERY: Behind the scenes at a cardiac ambulatory surgical center

A look inside a Banner Health cardiology ambulatory surgical center (ASC) in Sun City, Arizona.

READ MORE >
An outpatient EP lab at a Banner Health ambulatory surgical center (ASC) in Sun City, Arizona. The lab performs low-acuity, routine procedures so the main hospital EP lab can concentrate of more complex cases. Photo by Dave Fornell.
Share on Twitter Share on Facebook Share on Linkedin

PHOTO GALLERY: Behind the scenes at a cardiac ambulatory surgical center

Share on Twitter Share on Facebook Share on Linkedin
An outpatient EP lab at a Banner Health ambulatory surgical center (ASC) in Sun City, Arizona. The lab performs low-acuity, routine procedures so the main hospital EP lab can concentrate of more complex cases. Photo by Dave Fornell.
A look inside a Banner Health cardiology ambulatory surgical center (ASC) in Sun City, Arizona.
READ MORE >

In Case You Missed It

Transradial access should be ‘default strategy’ for PCI, new study confirms

Researchers explored data from nearly 25,000 PCI procedures, tracking the outcomes of patients treated with transradial access and transfemoral access. 

READ MORE >
Interventional cardiologists performing PCI
Share on Twitter Share on Facebook Share on Linkedin

Transradial access should be ‘default strategy’ for PCI, new study confirms

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologists performing PCI
Researchers explored data from nearly 25,000 PCI procedures, tracking the outcomes of patients treated with transradial access and transfemoral access. 
READ MORE >

Longevity, cardiovascular durability improve with just 1 or 2 walks per week

Weekend warriors who take brisk walks of around four miles just once or twice per week enjoy lower cardiovascular and all-cause mortality than their sedentary peers.

READ MORE >
Health walk heart health longevity
Share on Twitter Share on Facebook Share on Linkedin

Longevity, cardiovascular durability improve with just 1 or 2 walks per week

Share on Twitter Share on Facebook Share on Linkedin
Health walk heart health longevity
Weekend warriors who take brisk walks of around four miles just once or twice per week enjoy lower cardiovascular and all-cause mortality than their sedentary peers.
READ MORE >

In Other News

Serious patient safety events up 19% in 2022

A new report from the Joint Commission has laid bare a dramatic increase in sentinel events, up 19% in 2022 compared to the previous year, with the majority happening in hospital settings.

READ MORE >
Intensive Care Unit sign inside of a hospital
Share on Twitter Share on Facebook Share on Linkedin

Serious patient safety events up 19% in 2022

Share on Twitter Share on Facebook Share on Linkedin
Intensive Care Unit sign inside of a hospital
A new report from the Joint Commission has laid bare a dramatic increase in sentinel events, up 19% in 2022 compared to the previous year, with the majority happening in hospital settings.
READ MORE >

2 years on, lung damage scant in COVID survivors who were ventilated

Most patients who received mechanical ventilation for COVID-19 at a busy European hospital not only survived but also showed no scarring or thickening on lung CT at two years post-discharge.

READ MORE >
mechanical ventilation for covid
Share on Twitter Share on Facebook Share on Linkedin

2 years on, lung damage scant in COVID survivors who were ventilated

Share on Twitter Share on Facebook Share on Linkedin
mechanical ventilation for covid
Most patients who received mechanical ventilation for COVID-19 at a busy European hospital not only survived but also showed no scarring or thickening on lung CT at two years post-discharge.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Compensation still on the rise | Procedure kits recalled | A new definition of heart failure | Cardiologist named AHA president
New antiplatelet recommendations | Heart failure drug recalled | Imaging tech makes US debut | Conavi Medical's good news
Safety concerns lead to new recall | FDA approves surgical device | Parents in jail after obese son's death | A fraud warning
AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup